Real Situation Observational Study of Viraferonpeg [peginterferon-alfa-2b] in Patients With Chronic Hepatitis C
Phase of Trial: Phase IV
Latest Information Update: 07 Nov 2013
At a glance
- Drugs Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms ADEQUATION
- Sponsors Schering-Plough
- 25 Aug 2008 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 18 Jul 2008 New trial record.